351 related articles for article (PubMed ID: 35844143)
1. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
Huang MW; Gibson RC; Jayaram MB; Caroff SN
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013100. PubMed ID: 35844143
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Electroconvulsive therapy for treatment-resistant schizophrenia.
Sinclair DJ; Zhao S; Qi F; Nyakyoma K; Kwong JS; Adams CE
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011847. PubMed ID: 30888709
[TBL] [Abstract][Full Text] [Related]
4. Wendan decoction (Traditional Chinese medicine) for schizophrenia.
Deng H; Xu J
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012217. PubMed ID: 28657646
[TBL] [Abstract][Full Text] [Related]
5. Modafinil for people with schizophrenia or related disorders.
Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
[TBL] [Abstract][Full Text] [Related]
6. Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses.
Zaman H; Gibson RC; Walcott G
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD006570. PubMed ID: 31425609
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
8. Risperidone (depot) for schizophrenia.
Sampson S; Hosalli P; Furtado VA; Davis JM
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
[TBL] [Abstract][Full Text] [Related]
9. Selective noradrenaline reuptake inhibitors for schizophrenia.
Matthews PRL; Horder J; Pearce M
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010219. PubMed ID: 29368813
[TBL] [Abstract][Full Text] [Related]
10. Cannabis and schizophrenia.
McLoughlin BC; Pushpa-Rajah JA; Gillies D; Rathbone J; Variend H; Kalakouti E; Kyprianou K
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004837. PubMed ID: 25314586
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant treatments for schizophrenia.
Magalhães PV; Dean O; Andreazza AC; Berk M; Kapczinski F
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008919. PubMed ID: 26848926
[TBL] [Abstract][Full Text] [Related]
12. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
Barber S; Olotu U; Corsi M; Cipriani A
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
[TBL] [Abstract][Full Text] [Related]
13. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
Ostinelli EG; Hussein M; Ahmed U; Rehman FU; Miramontes K; Adams CE
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009412. PubMed ID: 29634083
[TBL] [Abstract][Full Text] [Related]
14. Cognitive behavioural therapy without medication for schizophrenia.
Bighelli I; Çıray O; Salahuddin NH; Leucht S
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD015332. PubMed ID: 38323679
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.
Rodolico A; Siafis S; Bighelli I; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014384. PubMed ID: 36420692
[TBL] [Abstract][Full Text] [Related]
16. Electroconvulsive therapy for schizophrenia.
Tharyan P; Adams CE
Cochrane Database Syst Rev; 2005 Apr; (2):CD000076. PubMed ID: 15846598
[TBL] [Abstract][Full Text] [Related]
17. Zuclopenthixol dihydrochloride for schizophrenia.
Bryan EJ; Purcell MA; Kumar A
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005474. PubMed ID: 29144549
[TBL] [Abstract][Full Text] [Related]
18. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
Temmingh HS; Williams T; Siegfried N; Stein DJ
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909
[TBL] [Abstract][Full Text] [Related]
19. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
Saha KB; Bo L; Zhao S; Xia J; Sampson S; Zaman RU
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010631. PubMed ID: 27045703
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders.
Ibragimov K; Keane GP; Carreño Glaría C; Cheng J; Llosa AE
Cochrane Database Syst Rev; 2024 Jul; 7():CD013425. PubMed ID: 38958149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
